Cargando...
Darbepoetin administration in Term and Preterm Neonates
PURPOSE OF REVIEW: The use of the erythropoiesis stimulating agent erythropoietin (Epo) has been studied as a red cell growth factor in preterm and term infants for over 20 years. Recent studies have evaluated Darbepoetin (Darbe, a long acting ESA) for both erythropoietic effects and potential neuro...
Gardado en:
| Publicado en: | Clin Perinatol |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
2015
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4529960/ https://ncbi.nlm.nih.gov/pubmed/26250917 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.clp.2015.04.016 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|